ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 115 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $417,770 | +70.9% | 93,461 | +22.7% | 0.00% | – |
| Q4 2023 | $244,474 | -9.4% | 76,160 | -10.5% | 0.00% | – |
| Q3 2023 | $269,899 | -54.6% | 85,142 | -28.8% | 0.00% | -100.0% |
| Q2 2023 | $593,990 | +13.6% | 119,515 | +12.9% | 0.00% | 0.0% |
| Q1 2023 | $522,850 | -18.8% | 105,840 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $644,253 | -27.5% | 102,425 | +24.4% | 0.00% | 0.0% |
| Q3 2022 | $889,000 | -4.3% | 82,317 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $929,000 | +51.1% | 81,391 | +20.6% | 0.00% | 0.0% |
| Q1 2022 | $615,000 | -36.3% | 67,493 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $965,000 | -51.9% | 64,668 | -17.2% | 0.00% | 0.0% |
| Q3 2021 | $2,006,000 | +4.0% | 78,067 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $1,929,000 | -12.3% | 73,972 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $2,199,000 | -34.1% | 62,289 | -52.9% | 0.00% | -50.0% |
| Q4 2020 | $3,336,000 | -24.0% | 132,164 | +13.6% | 0.00% | -33.3% |
| Q3 2020 | $4,388,000 | -15.7% | 116,367 | -4.3% | 0.00% | -25.0% |
| Q2 2020 | $5,207,000 | +263.1% | 121,612 | +64.8% | 0.00% | +300.0% |
| Q1 2020 | $1,434,000 | -57.5% | 73,806 | -43.1% | 0.00% | -50.0% |
| Q4 2019 | $3,371,000 | +542.1% | 129,742 | +572.9% | 0.00% | – |
| Q3 2019 | $525,000 | +40.4% | 19,280 | +38.1% | 0.00% | – |
| Q2 2019 | $374,000 | – | 13,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
| Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
| Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
| TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
| Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
| Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
| DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
| Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
| Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |